Trial intelligence / Profile preview

Anticipate Study: Proactive vs Rank-down Topical Corticosteroid Therapy in Pediatric Atopic Dermatitis

jRCTs031190047Completed

Sponsor
Torii Pharmaceutical
Start
Nov 2019
Countries
1
01

Overview

Randomised trial of corticosteroids in atopic dermatitis (AD) (2 arms), sponsored by Torii Pharmaceutical. Primary endpoint: Incidence of relapse during remission-maintenance treatment. Started Nov 2019; status: completed.

02

Drugs

corticosteroids
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on jRCTs031190047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031190047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call